SCHEMBL8911615

SCHEMBL8911615

O=[C]C(c1ccccc1)c1ccccn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.57
SLC6A4 P31645 2/20 0.57
SLC6A3 Q01959 2/20 0.57
ALDH1A1 P00352 3/20 0.46
CYP1A2 P05177 1/20 0.46
NPSR1 Q6W5P4 1/20 0.44
CHRM2 P08172 1/20 0.44
SCN1A P35498 1/20 0.44
SCN2A Q99250 1/20 0.44
SCN3A Q9NY46 1/20 0.44
KDM4E B2RXH2 3/20 0.42
TSHR P16473 3/20 0.39
CYP3A4 P08684 2/20 0.39
LMNA P02545 2/20 0.39
CYP2C19 P33261 1/20 0.39
RAB9A P51151 1/20 0.39
KCNA5 P22460 3/20 0.38
KCNE1 P15382 1/20 0.38
SLC10A1 Q14973 1/20 0.38
S1PR2 O95136 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4980374 0.88 SLC6A3 (0.48) SLC6A2SLC6A4SLC6A3ALDH1A1CYP1A2
SCHEMBL637183 0.81 SLC6A2 (0.57) SLC6A2SLC6A4SLC6A3ALDH1A1CYP1A2
SCHEMBL158475 0.76 SRC (0.42) TSHRLMNA
SCHEMBL8910189 0.74 SLC6A3 (0.58) SLC6A2SLC6A4SLC6A3ALDH1A1KDM4E
SCHEMBL9186509 0.74 SLC6A2 (0.63) SLC6A2SLC6A4SLC6A3ALDH1A1CYP1A2
SCHEMBL3751751 0.73 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3ALDH1A1CYP1A2
SCHEMBL10154156 0.73 SLC6A2 (0.91) SLC6A2SLC6A4SLC6A3ALDH1A1CYP1A2
SCHEMBL3290275 0.73 SLC6A3 (1.00) SLC6A2SLC6A4SLC6A3ALDH1A1CYP1A2
SCHEMBL30166037 0.73 SLC6A2 (0.91) SLC6A2SLC6A4SLC6A3ALDH1A1CYP1A2
SCHEMBL11516132 0.72 SLC6A3 (0.45) SLC6A2SLC6A4SLC6A3ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5622953-A DRUG RESISTANT TO ANTICANCER CHEMOTHERAPEUTIC DRUG BASF AKTIENGESELLSCHAFT (DE) 1997-04-22 US disclosed
EP-0691962-A1 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE BASF AKTIENGESELLSCHAFT (DE) 1996-01-17 EP disclosed
US-5405843-A Anticancer drug potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-04-11 US disclosed
EP-0363212-B1 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS (JP) 1995-01-04 EP disclosed
WO-1994022842-A1 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE BASF AKTIENGESELLSCHAFT (DE) 1994-10-13 WO disclosed
US-5204348-A Quinoline derivatives MITSUI TOATSU CHEMICALS INC. (JP) 1993-04-20 US disclosed
US-5112817-A Anticancer Drug Potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 US disclosed
EP-0363212-A2 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-04-11 EP disclosed